Keep the hope brother, 1801’s niche is (1) its synthetic CBD antimicrobial approach, which (2) is focused on nasal decolonisation/preventing infection in high-risk hospital patients.
RCE 327 is a synthetic antibiotic, designed to treat already active, systemic infections. Pivoting this to general preventative use, could further the AMR problem over the long term.
In a world where this AMR threat is growing, having multiple tools in the chest would also be prudent.
BOT Price at posting:
37.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)